# US 2008/0187567 A1 · N-substituted monomers and polymers

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0187567 A1
- Document ID: US20080187567A1
- Status: Published application
- Kind: A1
- Application number: 11/873,979
- Filed: 2007-10-17
- Published: 2008-08-07
- Earliest claimed: 2006-10-17
- Assignees: Rutgers, The State University of New Jersey
- Inventors: Joachim B. Kohn; Durgadas Bolikal; Jaap Schut; Ernest G. Baluca
- Web page: https://patentgrep.com/patent/US20080187567A1

## CPC

- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- C08G 63/6856: {Dicarboxylic acids and dihydroxy compounds}
- C08G 64/045: {containing aliphatic unsaturation}
- C08G 64/12: containing nitrogen
- C08G 64/183: {containing polyether sequences}
- C08G 64/186: {containing polysiloxane sequences}
- C08G 79/04: Phosphorus linked to oxygen or to oxygen and carbon
- C08L 85/02: containing phosphorus
- A61L 2300/00: Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- B33Y 80/00: Products made by additive manufacturing
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING

## Abstract

Biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an amide group, wherein said amide groups are N-substituted and the N-substituent and degree of N-substitution are effective to lower the melt viscosity, the solution viscosity, or both, compared to the same polymer without N-substitution.

## Claims

### Claim 1

Biocompatible, bioresorbable polymers comprising a plurality of monomeric repeating units containing an amide group, wherein said amide groups are N-substituted and the N-substituent and degree of N-substitution are effective to lower the melt viscosity, the solution viscosity, or both, compared to the same polymer without N-substitution.

### Claim 2 (depends on 1)

A polymer according to claim 1, wherein said N-substituents and degree of N-substitution are effective to reduce the melt viscosity, the solution viscosity, or both, at least about 5%.

### Claim 3 (depends on 1)

A polymer according to claim 1, wherein said N-substituents comprise C1-C6 alkyl groups.

### Claim 4 (depends on 1)

A polymer according to claim 1, comprising one or more recurring units of the formula:
wherein X1 and X2 are each independently selected from Br and I; y1 and y2 are each independently zero or an integer in the range of 1 to 4, and R1 is selected from the group consisting of substituted or unsubstituted, saturated or unsaturated, straight chain or branched aliphatic groups containing up to 48 carbon atoms, substituted or unsubstituted aromatic groups containing up to 48 carbon atoms, and substituted or unsubstituted araliphatic groups containing up to 48 carbon atoms in which the aliphatic portions are straight chain or branched and saturated or unsaturated, and R1 contains from 2 to 8 heteroatoms selected from O, S and N, in which two of the heteroatoms form a polymer backbone amide group that is N-substituted with a C1-C6 alkyl group.

### Claim 5 (depends on 4)

The polymer of claim 4, wherein said R1 group further comprises poly(alkylene oxide) heteroatoms.

### Claim 6 (depends on 4)

The polymer of claim 4, wherein R1 contains between about 18 and about 36 carbon atoms.

### Claim 7 (depends on 4)

The polymer of claim 4, wherein R1 is:
in which R13 and R14 each independently contain between 0 and 8 carbons atoms, inclusive, and are independently selected from (—CHR1)e—CH═CH—(CHR1—)e and (—CHR1)f(—CHNQ2)g(—CHR1)f, wherein R1 is H or lower alkyl, each e independently ranges between 0 and 6, inclusive, each f independently ranges between 0 and 8, inclusive and g is 0 or 1; Rx is a C1-C6 alkyl group; Q1 is C(=Z5)-R8, wherein Z5 is O or S; Q2 is —N(Rx)2 or —N(RxQ1) and R8 is selected from H, a therapeutically active moiety, a poly(alkylene oxide), —X3—C1-C18 alkyl, —X3-alkenyl, —X3-alkynyl, —X5-cycloalkyl, —X5-heterocyclyl, —X5-aryl and —X5-heteroaryl;
X3 is selected from a bond, O, S, and N-alkyl; and X5 is selected from a bond, lower alkyl, O, S and N-alkyl.

### Claim 8 (depends on 7)

A polymer according to claim 7, wherein R8 is an alkyl-terminated poly(alkylene oxide) selected from the group consisting of methoxy-terminated poly(ethylene glycols) (PEG) of molecular weight 100 to 10,000, methoxy-terminated poly(propylene glycols) (PPG) of molecular weight 100 to 10,000 and methoxy-terminated block copolymers of PEG and PPG of molecular weight 100 to 10,000.

### Claim 9 (depends on 4)

A polymer according to claim 4, wherein at least one monomeric aromatic ring of formula (I) is substituted with iodine, so that the sum of y1 and y2 in formula (I) is greater than zero.

### Claim 10 (depends on 7)

A polymer according to claim 7, wherein R8 is OH.

### Claim 11 (depends on 4)

A polymer according to claim 4, wherein R1 is selected from:
wherein Rx is a C1-C6 alkyl group; Z4 is O or S; a and b independently range between 0 and 8, inclusive; R8 is selected from H, a therapeutically active moiety, a poly(alkylene oxide), —X3—C1-C18 alkyl, —X3-alkenyl, —X3-alkynyl, —X5-cycloalkyl, —X5-hetero-cyclyl, —X5-aryl and —X5-heteroaryl;
X3 is selected from a bond, O, S, and N-alkyl; and X5 is selected from a bond, lower alkyl, O, S and N-alkyl.

### Claim 12 (depends on 4)

A polymer according to claim 4, characterized by being a polycarbonate, polyarylate, polyiminocarbonate, polyphosphazene or polyphosphoester having the structure of formula (Ia),
wherein X1 and X2 are each independently selected from Br and I; y1 and y2 are each independently zero or an integer in the range of 1 to 4, and R1 is selected from the group consisting of substituted or unsubstituted, saturated or unsaturated, straight chain or branched aliphatic groups containing up to 48 carbon atoms, substituted or unsubstituted aromatic groups containing up to 48 carbon atoms, and substituted or unsubstituted araliphatic groups containing up to 48 carbon atoms in which the aliphatic portions are straight chain or branched and saturated or unsaturated, and R1 contains from 2 to 8 heteroatoms selected from O, S and N, in which two of the heteroatoms form a polymer backbone amide group that is N-substituted with a C1-C6 alkyl group and
A1 is selected from the group consisting of:
wherein R10 is selected from H, C1-C30 alkyl, alkenyl or alkynyl and C2-C30 heteroalkyl; heteroalkenyl or heteroalkynyl, and R12 is selected from C1-C30 alkyl, alkenyl or alkynyl, C1-C30 heteroalkyl; heteroalkenyl or heteroalkynyl, C5-C30 heteroalkylaryl, heteroalkenylary or heteroalkynylaryl, C6-C30 alkylaryl, alkenylaryl or alkynylaryl, and C5-C30 heteroaryl.

### Claim 13 (depends on 4, 12)

A polymer according to claim 4 or claim 12, further comprising recurring polyalkylene oxide block units comprising repeating units with the structure:
wherein B is —O—((CHR6)p—O)q—; each R6 is independently H or C1 to C3 alkyl; p is an integer ranging between one and four, inclusive; q is an integer ranging between about five and about 3000; and A2 is the same as A1.

### Claim 14 (depends on 4, 12)

The polymer of claim 4 or claim 12, characterized by being a copolymer of a diphenol monomer that is not N-substituted.

### Claim 15

A diphenol compound with an amide groups that are N-substituted.

### Claim 16 (depends on 15)

The diphenol compound of claim 15, wherein said N-substituent is a C1-C6 alkyl group.

### Claim 17

N-substituted diphenol compounds having the structure:
wherein X1 and X2 are each independently selected from Br and I; y1 and y2 are each independently zero or an integer in the range of 1 to 4, and R1 is selected from the group consisting of substituted or unsubstituted, saturated or unsaturated, straight chain or branched aliphatic groups containing up to 48 carbon atoms, substituted or unsubstituted aromatic groups containing up to 48 carbon atoms, and substituted or unsubstituted araliphatic groups containing up to 48 carbon atoms in which the aliphatic portions are straight chain or branched and saturated or unsaturated, and R1 contains from 2 to 8 heteroatoms selected from O, S and N, in which two of the heteroatoms form a polymer backbone amide group that is N-substituted with a C1-C6 alkyl group.

### Claim 18 (depends on 17)

The diphenol compound of claim 17, wherein R1 is:
in which R13 and R14 each independently contain between 0 and 8 carbons atoms, inclusive, and are independently selected from (—CHR1)e—CH═CH—(CHR1—)e and (—CHR1)f(—CHNQ2)g(—CHR1)f, wherein R1 is H or lower alkyl, each e independently ranges between 0 and 6, inclusive, each f independently ranges between 0 and 8, inclusive and g is 0 or 1; Rx is a C1-C6 alkyl group; Q1 is C(=Z5)-R8, wherein Z5 is O or S; Q2 is —N(Rx)2 or —N(RxQ1) and R8 is selected from H, a therapeutically active moiety, a poly(alkylene oxide), —X3—C1-C18 alkyl, —X3-alkenyl, —X3-alkynyl, —X5-cycloalkyl, —X5-heterocyclyl, —X5-aryl and —X5-heteroaryl;
X3 is selected from a bond, O, S, and N-alkyl; and X5 is selected from a bond, lower alkyl, O, S and N-alkyl.

### Claim 19 (depends on 18)

The diphenol compound of claim 18, wherein R8 is an alkyl-terminated poly(alkylene oxide) selected from the group consisting of methoxy-terminated poly(ethylene glycols) (PEG) of molecular weight 100 to 10,000, methoxy-terminated poly(propylene glycols) (PPG) of molecular weight 100 to 10,000 and methoxy-terminated block copolymers of PEG and PPG of molecular weight 1,00 to 10,000.

### Claim 20 (depends on 18)

A diphenol compound according to claim 18, wherein R1 is selected from:
wherein Rx is a C1-C6 alkyl group; Z4 is O or S; a and b independently range between 0 and 8, inclusive; R8 is selected from H, a therapeutically active moiety, a poly(alkylene oxide), —X3—C1-C18 alkyl, —X3-alkenyl, —X3-alkynyl, —X5-cycloalkyl, —X5-heterocyclyl, —X5-aryl and —X5-heteroaryl;
X3 is selected from a bond, O, S, and N-alkyl; and X5 is selected from a bond, lower alkyl, O, S and N-alkyl.

### Claim 21 (depends on 17)

The diphenol compound of claim 17, wherein R1 is selected to define an N,N-disubstituted dityrosine.

### Claim 22 (depends on 1)

A blood-contacting or tissue-implantable medical device formed from a polymer of claim 1.

### Claim 23 (depends on 1)

An implantable drug delivery device comprising a therapeutically effective amount of a biologically or a physiologically active compound in combination with a polymer according to claim 1.
